The score is not available for this stock. This could be because (a) the market cap of the... Read More
Value score
The score is not available for this stock. This could be because (a) the market cap of the... Read More
Price Momentum score
The score is not available for this stock. This could be because (a) the market cap of the... Read More
QVM score
The score is not available for this stock. This could be because (a) the market cap of the... Read More
530125-BOM Key Metrics
530125-BOM Share Price
Stock Analysis
Snapshot
Shareholding Pattern
Bulk, Block & Insider Trades
Corporate Actions
Company Profile
530125-BOM Share Price
530125-BOM
1 Week returns: -
1 Month returns: -
1 Year returns: -
3 Years CAGR: -
5 Years CAGR: -
Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
530125-BOM Stock Analysis
Views
Red Flags
Positive
Low Debt to Equity, not much change from last year
Company is net cash
Negative
Expensive and at a premium to industry median P/E
Low and declining ROE
Low but stable operating margin
Low revenue growth and lower than median growth of industry
Low EPS growth and lower than median growth of industry
Low dividend yield
Neutral
Not enough talking point with neutral stance
Thinly traded (low daily turnover)
The stock is thinly traded with combined (NSE & BSE) daily turnover (21-day average) of 0.0447372.
Snapshot
See detailed analysis
530125-BOM Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
530125-BOM Bulk, Block & Insider Trades
530125-BOM Dividends, Splits & Bonus
Dividend Events
Capital Change Events
No capital change events found
Company Profile
Samrat Pharmachem Limited is an India-based manufacturer of iodine salts. The Company is engaged in the business of pharmaceutical chemicals. Its products include 3-5 Di Iodosalicylic Acid, Ammonium Iodide, Cadmium Iodide, Calcium Iodate, Clioquinol, Copper Iodide, Ethyl Iodide, Ethylenediamine Dihy... Read More
Key personnel
Mr. Lalit Damodar MehtaD
Executive Chairman of the Board, Managing Director
Mr. Nishant Kumar Kankaria
Compliance Officer, Company Secretary
Mr. Megh Rajesh MehtaD
Executive Director
Mr. Rajesh Lalit MehtaD
Executive Director
Mr. Piyush Gangji DharodD
Additional Non-Executive Independent Director
Ms. Megha JainD
Non-Executive Independent Director
Mr. Sachin KotharyD
Non-Executive Independent Director
Mr. Manishkumar PipaliaD
Non-Executive Independent Director
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Samrat Pharmachem Ltd.?
The current share price of Samrat Pharmachem Ltd. is ₹ 222.05 as of 09 Jan 2026.
What is the PE ratio of Samrat Pharmachem Ltd.?
The Price-to-Earnings (PE) ratio of Samrat Pharmachem Ltd. is 43.72 as of the latest financial data.
What is the ROE and ROCE of Samrat Pharmachem Ltd.?
Samrat Pharmachem Ltd. has a Return on Equity (ROE) of 2.24% and a Return on Capital Employed (ROCE) of 4.22% as per the latest financial reports.
What is the market cap of Samrat Pharmachem Ltd.?
The market capitalization of Samrat Pharmachem Ltd. stands at ₹ 68.61 Cr.
What is the dividend yield of Samrat Pharmachem Ltd.?
The dividend yield of Samrat Pharmachem Ltd. is 0.45% based on the current market price.
What is the RSI of Samrat Pharmachem Ltd.?
The Relative Strength Index (RSI) of Samrat Pharmachem Ltd. is 37.02.
What is the FII and DII holding in Samrat Pharmachem Ltd.?
Foreign Institutional Investors (FII) hold 0.00% and Domestic Institutional Investors (DII) hold 0.00% of Samrat Pharmachem Ltd. shares.
What sector does Samrat Pharmachem Ltd. belong to?
Samrat Pharmachem Ltd. operates in the Healthcare sector.
What is the beta of Samrat Pharmachem Ltd. stock?
The beta of Samrat Pharmachem Ltd. stock is 0.93, indicating its volatility relative to the broader market.
